Increased Levels of sCD30 Have No Impact on the Incidence of Early ABMR and Long-Term Outcome in Intermediate-Risk Renal Transplant Patients With Preformed DSA

Background: It is still incompletely understood why some patients with preformed donor-specific anti-HLA antibodies (DSA) have reduced kidney allograft survival secondary to antibody-mediated rejection (ABMR), whereas many DSA-positive patients have favorable long-term outcomes. Elevated levels of s...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Thomas Drasch, Christian Bach, Markus Luber, Bernd Spriewald, Kirsten Utpatel, Maike Büttner-Herold, Bernhard Banas, Daniel Zecher
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/6777b0a68ea045898933956d874c2fa9
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!